InsidersTradesSigma
Acarix AB: insider trades · Finland · FIN-FSA
FI:acarix-abSE0009268717FI·FIN-FSAMcap 303M€Healthcare
Discover the full management transaction log of Acarix AB, a listed equity based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Acarix AB has published 5 reports. Market capitalisation: €302.8m. The latest transaction was reported on 22 September 2025 — Purchase. Among the most active insiders: Aamir Mahmood. The full history is openly available.
5
Insider Decl.
0
Thresholds
€72,006
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.26 €
Analyst consensus
1 analysts0.40 €Target 0.40 €(+54%)0.40 €
Income statement
Revenue7.4 M€
Gross profit6.2 M€85% margin
Net income−48.1 M€-653.3% margin
Valuation
P/Book7.9x
Beta-0.26
Balance sheet & cash
Market cap302.8 M€
Free Cash Flow−38.0 M€
Profitability & ownership
ROE-84.5%
ROA-46.5%
% insiders15.3%
% institutions1.3%
Last declaration on 22 September 2025
Declarations5 total
Executives●Purchase15FIN-FSA
€4,065150,000 shares@ €0.02710.0013% mcap100.0% of flow
Aktie
FI:A003S480-1·
Ideal exit: 14 Jun 2026 (T+270)
Executives●Purchase26FIN-FSA
€10,140385,553 shares@ €0.02630.0033% mcap14.9% of flow
Aktie
FI:A003S110-1·
Ideal exit: 2 Jun 2026 (T+270)
Executives●Purchase24FIN-FSA
€14,547588,753 shares@ €0.02470.0048% mcap21.4% of flow
Aktie
FI:A003H027-2·
Ideal exit: 26 May 2025 (T+270)
Executives●Purchase27FIN-FSA
€28,1301,382,000 shares@ €0.02040.0093% mcap41.4% of flow
Aktie
FI:A003L497-2·
Ideal exit: 10 Nov 2025 (T+270)
Executives●Purchase24FIN-FSA
€15,124751,549 shares@ €0.02010.0050% mcap22.3% of flow
Aktie
FI:A003M644-2·
Ideal exit: 7 Dec 2025 (T+270)
5 of 5 declarations